Advertisement
Screener

Fusion Pharmaceuticals Inc. Form 10-K: Annual report

Fusion Pharmaceuticals Inc. Form 10-K: Annual report

Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.

  • 2024-03-20: Form 10-K; Period of report 2023-12-31; Description 10-K; Document fusn-20231231.htm.
  • 2023-03-16: Form 10-K; Period of report 2022-12-31; Description 10-K; Document fusn-20221231.htm.
  • 2022-03-17: Form 10-K; Period of report 2021-12-31; Description 10-K; Document fusn-10k_20211231.htm.
  • 2021-03-25: Form 10-K; Period of report 2020-12-31; Description 10-K; Document fusn-10k_20201231.htm.
FiledFormPeriod of reportDescriptionDocument
2024-03-2010-K2023-12-3110-Kfusn-20231231.htm
2023-03-1610-K2022-12-3110-Kfusn-20221231.htm
2022-03-1710-K2021-12-3110-Kfusn-10k_20211231.htm
2021-03-2510-K2020-12-3110-Kfusn-10k_20201231.htm